Sign inGet started

MELAS KYRIAZI THEO

Insider CIK 1216078 · CDAK Director · EVLO Director · KLDO Director · VRX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
EVLO Evelo Biosciences, Inc. A Award deriv2023-06-082023-06-1220,000— $020,000SEC↗
CDAK Codiak BioSciences, Inc. M Exercise deriv2023-02-162023-02-218,750— $00SEC↗
CDAK Codiak BioSciences, Inc. M Exercise2023-02-162023-02-218,750— $015,350SEC↗
CDAK Codiak BioSciences, Inc. A Award deriv2022-06-172022-06-217,500— $07,500SEC↗
CDAK Codiak BioSciences, Inc. A Award deriv2022-06-172022-06-211,500— $01,500SEC↗
EVLO Evelo Biosciences, Inc. A Award deriv2022-06-092022-06-1320,000— $020,000SEC↗
CDAK Codiak BioSciences, Inc. A Award deriv2022-02-162022-02-188,750— $08,750SEC↗
KLDO Kaleido Biosciences, Inc. A Award deriv2021-06-302021-07-0115,000— $015,000SEC↗
CDAK Codiak BioSciences, Inc. A Award deriv2021-06-182021-06-2210,000— $010,000SEC↗
EVLO Evelo Biosciences, Inc. A Award deriv2021-06-092021-06-111,810— $01,810SEC↗
EVLO Evelo Biosciences, Inc. A Award deriv2021-06-082021-06-1115,690— $015,690SEC↗
CDAK Codiak BioSciences, Inc. P Buy2020-10-132021-04-306,600$15.00 $99.0K6,600SEC↗
CDAK Codiak BioSciences, Inc. A Award deriv2020-10-132020-10-1510,000— $010,000SEC↗
KLDO Kaleido Biosciences, Inc. A Award deriv2020-06-302020-07-0115,000— $015,000SEC↗
EVLO Evelo Biosciences, Inc. A Award deriv2020-06-172020-06-1815,690— $015,690SEC↗
KLDO Kaleido Biosciences, Inc. P Buy2020-06-042020-06-0533,333$7.50 $250.0K33,333SEC↗
KLDO Kaleido Biosciences, Inc. A Award deriv2019-07-312019-08-0193,531— $093,531SEC↗
EVLO Evelo Biosciences, Inc. A Award deriv2019-06-122019-06-1315,690— $015,690SEC↗
VRX Valeant Pharmaceuticals In A Award2016-05-022016-05-04950— $0223,087SEC↗
VRX Valeant Pharmaceuticals In A Award2015-12-312016-01-04245— $0222,137SEC↗
VRX Valeant Pharmaceuticals In A Award2015-09-302015-10-02140— $0221,892SEC↗
VRX Valeant Pharmaceuticals In A Award2015-06-302015-07-02106— $0221,752SEC↗
VRX Valeant Pharmaceuticals In A Award2015-05-222015-05-271,607— $0221,646SEC↗
VRX Valeant Pharmaceuticals In A Award2015-03-312015-04-02132— $0220,039SEC↗
VRX Valeant Pharmaceuticals In A Award2014-12-312015-01-05192— $0219,907SEC↗
VRX Valeant Pharmaceuticals In A Award2014-09-302014-10-02209— $0219,715SEC↗
VRX Valeant Pharmaceuticals In A Award2014-06-302014-07-01228— $0219,506SEC↗
VRX Valeant Pharmaceuticals In A Award2014-05-232014-05-282,866— $0219,278SEC↗
VRX Valeant Pharmaceuticals In A Award2014-03-312014-04-02224— $0216,412SEC↗
VRX Valeant Pharmaceuticals In A Award2013-12-312014-01-02250— $0157,206SEC↗
VRX Valeant Pharmaceuticals In A Award2013-12-312014-01-02250— $0216,188SEC↗
VRX Valeant Pharmaceuticals In A Award2013-09-302013-10-02281— $0215,938SEC↗
VRX Valeant Pharmaceuticals In A Award2013-06-302013-07-02316— $0215,657SEC↗
VRX Valeant Pharmaceuticals In F Tax w/h2013-06-042013-06-06924$88.21 $81.5K215,341SEC↗
VRX Valeant Pharmaceuticals In D To issuer deriv2013-05-302013-06-031,320— $0513SEC↗
VRX Valeant Pharmaceuticals In A Award2013-05-302013-06-031,320— $0223,027SEC↗
VRX Valeant Pharmaceuticals In F Tax w/h2013-05-302013-06-036,762$90.81 $614.1K216,265SEC↗
VRX Valeant Pharmaceuticals In A Award2013-05-242013-05-285,022— $0221,707SEC↗
VRX Valeant Pharmaceuticals In A Award2013-03-312013-04-02341— $0216,685SEC↗
VRX Valeant Pharmaceuticals In A Award2012-12-312013-01-03428— $0216,379SEC↗
VRX Valeant Pharmaceuticals In A Award2012-12-312013-01-04428— $0216,344SEC↗
VRX Valeant Pharmaceuticals In A Award2012-12-312013-01-04428— $0216,344SEC↗
VRX Valeant Pharmaceuticals In A Award2012-09-302012-10-02463— $0215,916SEC↗
VRX Valeant Pharmaceuticals In A Award2012-06-302012-07-03596— $0215,453SEC↗
VRX Valeant Pharmaceuticals In A Award2012-06-042012-06-048,062— $0214,857SEC↗
VRX Valeant Pharmaceuticals In A Award2012-03-312012-04-03500— $0206,795SEC↗